The Link between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer|
Resistance to the latest advanced prostate cancer therapies, including abiraterone and enzalutamide, is associated with increased expression of constitutively active androgen receptor splice variants. The authors examine androgen receptor splice variants as an alternative mechanism by which prostate cancer becomes resistant to androgen receptor-directed therapy. [Horm Cancer]
Visit our reviews page to see a complete list of reviews in the prostate cell research field.
Have we missed an important article or publication in Prostate Cell News? Click here to submit!
Comments or Suggestions? Submit your feedback here.